The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.Source: Reuters
Artificial intelligence healthcare technology company Medopad has just landed $28 million in a Series A funding round with lead investments from ChinaĆ¢??s NWS Holdings. But the company announced that its goal is to raise $120 million in the next few months.Source: Mobilehealth News
A trio of presenters at HIMSS 2018 shared data from practical machine learning and AI-focused studies that demonstrate how the technologies could reduce costs and improve patients' outcomes.Source: Mobile Health News
Password reset link has been sent to your mail
Thank you for your registration has been Successfully done.